InMed Pharmaceuticals Inc
NASDAQ:INM 10:44:35 AM EDT
Market Cap (Intraday) | 1.00M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $0.32 |
50-Day MA | $0.36 |
200-Day MA | $0.57 |
InMed Pharmaceuticals Inc Stock, NASDAQ:INM
815 West Hastings Street, Suite 310, Vancouver, British Columbia V6C 1B4
Canada
Phone: +1.604.669.7207
Number of Employees: 13
Description
InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It operates through the InMed and BayMedica segments. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.